Expanding Scale and Store Network through M&A and New Store Openings
First written in FY2016. 38 of 44 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-09-17.
0 other companies' latest entry also says "Cited as achieved".
- FY2026AdvancedAnnual report
「At the end of the fiscal year, the number of dispensing pharmacy stores was 406, an increase of 23 stores and a decrease of 18 stores from the end of the previous fiscal year. Of the increase, 16 stores came from 株式会社三幸メディカルグループ, which joined the Group on 13 February 2026.」
The acquisition of 株式会社三幸メディカル, 大洋薬品 and 平成薬品, among others, expanded the dispensing pharmacy store count from 401 to 406. - FY2026-H1AdvancedAnnual report
「As a result of proactively pursuing M&A during the previous fiscal year as a measure to strengthen earnings in the core dispensing pharmacy business, the Group increased revenue. Its rapid post-acquisition integration efforts have also contributed steadily to profit growth.」
The Group states that the M&A pursued in the previous year contributed not only to store count and revenue growth but also to higher profit through post-acquisition integration. - FY2025AdvancedAnnual report
「The Group pursued expansion through proactive M&A and worked to improve profitability by closing unprofitable stores after assessing their earnings potential. During the fiscal year, the number of dispensing pharmacy stores increased by 61, including 54 stores from next PH株式会社, and decreased by 11, bringing the total operated by the Group to 401.」
M&A and business transfers involving the GOOD AID Group and the 寛一商店 Group, among others, increased the store count by 61, while 11 stores were reduced, bringing the total to 401. - FY2025-H1AdvancedAnnual report
「At a Board of Directors meeting held on 24 September 2024, the Company resolved to accept the transfer of part of the business of the 寛一商店 Group and entered into a business transfer agreement on the same date. At a Board meeting held on 17 October 2024, the Company resolved to transfer the business acquired in this transaction to next PH株式会社, a subsidiary established on 10 October 2024, through an absorption-type company split. The transfer was completed on 2 December 2024.」
The Company assumed the dispensing pharmacy business of the 寛一商店 Group through a business transfer, completed on 2 December 2024, thereby advancing the expansion of the dispensing pharmacy business through M&A. - FY2024AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 59 and decreased by 8, bringing the number of stores operated by the Group to 351.」
The acquisition of the GOOD AID Group, 有限会社ミット, 三協医療薬品 and 佐々浪ファーマシー, among others, expanded the dispensing pharmacy network to 351 stores. The acquisition cost for GOOD AID was ¥2,711 million and the voting rights ratio was 100.0%. - FY2024-Q3AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 18 and decreased by 5, bringing the number of stores operated by the Group to 313. The additions comprised newly opened stores and stores acquired through share transfers from 有限会社ミット, 三協医療薬品株式会社 and 株式会社佐々浪ファーマシー. (Including the GOOD AID Group, the total number of stores was 352.)」
The acquisition of stores operated by 有限会社ミット, 三協医療薬品 and 佐々浪ファーマシー and new store openings increased the dispensing pharmacy total by 18, while 5 stores were reduced, leaving 313. The Company also disclosed the acquisition of all shares of GOOD AID株式会社, which was expected to bring the total including that group to 352 stores. The acquisition cost for GOOD AID was ¥2,711 million and the post-acquisition voting rights ratio was 100.0%. - FY2024-Q2AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 12 and decreased by 2, bringing the number of stores operated by the Group to 310. The additions comprised 3 stores in Tokyo acquired through a share transfer from 三協医療薬品株式会社, 6 stores from 有限会社ミット, including 1 in Fukushima and 5 in Niigata, and 3 newly opened stores operated by ファーマライズ株式会社 in Ibaraki, Kanagawa and Osaka.」
The acquisitions of 三協医療薬品 and 有限会社ミット, together with new store openings, increased the dispensing pharmacy store count by 12, while 2 stores were reduced, bringing the total to 310. - FY2024-Q1AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 2 and decreased by 1, bringing the number of stores operated by the Group to 301. The additions were 2 newly opened stores in Ibaraki and Kanagawa operated by ファーマライズ株式会社.」
The Group opened 2 stores in Ibaraki and Kanagawa and reduced its store count by 1, increasing the dispensing pharmacy total from 300 to 301. - FY2023AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 8 and decreased by 9, bringing the number of stores operated by the Group to 300. The additions comprised 2 stores in Kanagawa acquired through a share transfer from 有限会社映双薬局, 1 store in Mie acquired from 株式会社くすき調剤薬局, 1 store in Hokkaido acquired from 有限会社池本薬局, 2 stores in Mie acquired from 有限会社大木薬局, and 2 newly opened stores operated by ファーマライズ株式会社 in Tochigi and Osaka.」
The acquisitions of 映双薬局, くすき調剤薬局, 池本薬局 and 大木薬局, together with new store openings, added 8 stores, while 9 stores were reduced, leaving 300 at period-end. - FY2023-Q3New Store and M&A Activity and Store Count DeclineAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 6 and decreased by 9, bringing the number of stores operated by the Group to 298. The additions comprised 2 stores in Kanagawa acquired through a share transfer from 有限会社映双薬局, 1 store in Mie acquired from 株式会社くすき調剤薬局, 1 store in Hokkaido acquired from 有限会社池本薬局, and 2 newly opened stores operated by ファーマライズ株式会社 in Tochigi and Osaka.」
The Group acquired 4 stores and opened 2, but reduced its store count by 9, bringing the dispensing pharmacy total down from 305 at the prior quarter-end to 298. - FY2023-Q2AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 5 and decreased by 1, bringing the number of stores operated by the Group to 305. The additions comprised 2 stores in Kanagawa acquired through a share transfer from 有限会社映双薬局, 1 store in Mie acquired from 株式会社くすき調剤薬局, 1 store in Hokkaido acquired from 有限会社池本薬局, and 1 newly opened store in Osaka operated by ファーマライズ株式会社.」
The acquisitions of 有限会社映双薬局, 株式会社くすき調剤薬局 and 有限会社池本薬局, together with a new store opening, expanded the dispensing pharmacy network to 305 stores. - FY2023-Q1AdvancedAnnual report
「During the same period, the number of dispensing pharmacy stores increased by 3 and decreased by 1, bringing the number of stores operated by the Group to 303. The additions comprised 2 stores in Kanagawa acquired through a share transfer from 有限会社映双薬局 and 1 newly opened store in Osaka operated by ファーマライズ株式会社.」
The acquisition of 2 stores from 有限会社映双薬局 and the opening of 1 store in Osaka increased the dispensing pharmacy store count to 303. - FY2022AdvancedAnnual report
「During the fiscal year, the number of dispensing pharmacy stores increased by 9 and decreased by 6, bringing the number of stores operated by the Group to 301 at year-end.」
The Group opened 9 stores and closed or suspended 6, expanding the dispensing pharmacy store count from 298 at the prior year-end to 301. - FY2022-Q3AdvancedAnnual report
「During the nine-month period ended 28 February, the number of dispensing pharmacy stores increased by 6 and decreased by 5, bringing the number of stores operated by the Group to 299 at period-end. The additions comprised 1 newly opened store in Hokkaido, 1 in Niigata, 1 in Tokyo, 1 in Aichi, 1 in Osaka and 1 in Okinawa operated by ファーマライズ株式会社.」
The Group opened 6 stores in Hokkaido, Niigata, Tokyo, Aichi, Osaka and Okinawa and reduced its store count by 5, increasing the total from 297 at the prior quarter-end to 299. - FY2022-Q2AdvancedAnnual report
「During the six-month period ended 30 November, the number of dispensing pharmacy stores increased by 4 and decreased by 5, bringing the number of stores operated by the Group to 297 at period-end. The additions comprised 1 newly opened store in Hokkaido, 1 in Tokyo, 1 in Aichi and 1 in Okinawa operated by ファーマライズ株式会社.」
The Group opened 4 stores in Hokkaido, Tokyo, Aichi and Okinawa and reduced its store count by 5, leaving 297 dispensing pharmacy stores at period-end. - FY2022-Q1AdvancedAnnual report
「During the three-month period ended 31 August, the number of dispensing pharmacy stores increased by 3 and decreased by 4, bringing the number of stores operated by the Group to 297 at period-end. The additions comprised 1 newly opened store in Hokkaido, 1 in Aichi and 1 in Okinawa operated by ファーマライズ株式会社.」
The Group opened 3 stores in Hokkaido, Aichi and Okinawa while reducing its store count by 4, leaving 297 dispensing pharmacy stores at period-end. - FY2021AdvancedAnnual report
「During the fiscal year, the number of dispensing pharmacy stores increased by 8 and decreased by 4, bringing the number of stores operated by the Group to 298 at year-end.」
The Group expanded its store network through new store openings and M&A, adding 8 stores and reducing 4 during the year to end with 298 stores. - FY2021-Q3AdvancedAnnual report
「During the nine-month period ended 28 February, the number of dispensing pharmacy stores increased by 7 and decreased by 3, bringing the number of stores operated by the Group to 298 at period-end. The additions comprised 2 newly opened stores in Tokyo, 1 in Kanagawa and 1 in Osaka operated by ファーマライズ㈱, 1 newly opened store in Nara operated by ㈱ヘルシーワーク, and 1 newly acquired store in Chiba and 1 newly opened store in Ishikawa operated by ㈲サン・メディカル.」
New store openings and acquisitions increased the dispensing pharmacy store count by 7, while 3 stores were reduced, bringing the total to 298. - FY2021-Q2AdvancedAnnual report
「During the six-month period ended 30 November, the number of dispensing pharmacy stores increased by 7 and decreased by 2, bringing the number of stores operated by the Group to 299 at period-end. The additions comprised 2 newly opened stores in Tokyo, 1 in Kanagawa and 1 in Osaka operated by ファーマライズ㈱, 1 newly opened store in Nara operated by ㈱ヘルシーワーク, and 1 newly acquired store in Chiba and 1 newly opened store in Ishikawa operated by ㈲サン・メディカル.」
New store openings and acquisitions increased the dispensing pharmacy store count by 7, while 2 stores were reduced, bringing the total to 299. - FY2020AdvancedAnnual report
「During the fiscal year, the number of dispensing pharmacy stores increased by 41 and decreased by 5, bringing the number of stores operated by the Group to 294 at year-end.」
The acquisition of アマゾンファーマシー, ヘルシーワーク and サン・メディカル, together with new store openings, expanded the dispensing pharmacy network to 294 stores. - FY2020-Q3AdvancedAnnual report
「During the nine-month period ended 28 February, the number of dispensing pharmacy stores increased by 6 and decreased by 4, bringing the number of stores operated by the Group to 260 at period-end. The additions comprised 1 store in Shizuoka acquired through a share transfer from 有限会社アマゾンファーマシー and newly opened stores operated by ファーマライズ株式会社, 1 each in Tokyo, Kanagawa and Kyoto, and 2 in Osaka.」
The Company disclosed specific store additions and reductions, including the acquisition of 有限会社アマゾンファーマシー and 5 new store openings. It also disclosed that 株式会社ヘルシーワーク, which operated 31 stores, and 有限会社サン・メディカル, which operated 2 stores in Kanagawa, became consolidated subsidiaries after the period. - FY2020-Q2AdvancedAnnual report
「During the six-month period ended 30 November, the number of dispensing pharmacy stores increased by 5, bringing the number of stores operated by the Group to 263 at period-end. The additions comprised 1 store in Shizuoka acquired through a share transfer from 有限会社アマゾンファーマシー and newly opened stores operated by ファーマライズ株式会社, 1 in Tokyo, 1 in Kanagawa and 2 in Osaka.」
The acquisition of 有限会社アマゾンファーマシー and the opening of 4 new stores increased the dispensing pharmacy store count by 5 to 263. - FY2020-Q1AdvancedAnnual report
「During the three-month period ended 31 August, the number of dispensing pharmacy stores increased by 4, bringing the number of stores operated by the Group to 262 at period-end. The additions comprised 1 store in Shizuoka acquired through a share transfer from 有限会社アマゾンファーマシー and newly opened stores operated by ファーマライズ株式会社, 1 in Tokyo, 1 in Kanagawa and 1 in Osaka.」
The acquisition of all shares of 有限会社アマゾンファーマシー and the opening of 3 new stores increased the dispensing pharmacy store count by 4 to 262. - FY2019-Q3AdvancedAnnual report
「During the nine-month period ended 28 February, the number of dispensing pharmacy stores increased by 10 and decreased by 5, bringing the number of stores operated by the Group to 260 at period-end. The additions comprised 6 stores in Nagasaki operated by 株式会社ケミスト, which became a consolidated subsidiary, 1 store each in Gunma and Saitama operated by ファーマライズ株式会社, 1 store in Hokkaido operated by 北海道ファーマライズ株式会社, and 1 store in Osaka operated by 関西ファーマライズ株式会社.」
The number of dispensing pharmacy stores reached 260 after 10 additions and 5 reductions, including the 6 stores of 株式会社ケミスト, which became a consolidated subsidiary. - FY2019-Q2AdvancedAnnual report
「This was because the Company acquired all of the issued shares of 株式会社ケミスト for cash consideration.」
On 1 October 2018, the Company acquired 100% of the voting rights of 株式会社ケミスト for ¥162 million, expanding and strengthening the dispensing pharmacy business. The new medium-term management plan also called for accelerating new store openings and M&A. - FY2019-Q1AdvancedAnnual report
「During the three-month period ended 31 May, the number of dispensing pharmacy stores increased by 2 and decreased by 2, bringing the number of stores operated by the Group to 255 at period-end. The stores added were 1 store in Gunma operated by ファーマライズ株式会社 and 1 store in Hokkaido operated by 北海道ファーマライズ株式会社.」
The Group opened 2 stores in Gunma and Hokkaido while reducing its store count by 2, leaving 255 dispensing pharmacy stores at period-end. - FY2018AdvancedAnnual report
「During the fiscal year, the number of dispensing pharmacy stores increased by 8 and decreased by 8, bringing the number of stores operated by the Group to 255 at year-end.」
The Group opened 8 stores and reduced its store count by 8 during the year, ending with 255 stores. - FY2018-Q3AdvancedAnnual report
「Effective 1 December 2017, 株式会社双葉, which operated 8 stores in Kyoto, was absorbed by 株式会社テラ・ヘルスプロモーション, the surviving company, and 有限会社イノセ商事, which operated 1 store in Saitama, was absorbed by ファーマライズ株式会社, the surviving company. On the same date, 1 store operated in Osaka by 新世薬品株式会社 was transferred to 株式会社テラ・ヘルスプロモーション through an absorption-type company split.」
Effective 1 December 2017, the Group completed the absorption-type mergers of 株式会社双葉 and 有限会社イノセ商事 and transferred 1 store of 新世薬品株式会社 through an absorption-type company split, advancing the expansion and restructuring of its business platform. - FY2018-Q2AdvancedAnnual report
「During the six-month period ended 30 September, the number of dispensing pharmacy stores increased by 6 and decreased by 1, bringing the number of stores operated by the Group to 260 at period-end.」
The Group added 6 dispensing pharmacy stores and closed 1 during the six-month period, ending with 260 stores. 有限会社イノセ商事, 株式会社エム・シー and 株式会社ミュートス, which joined the Group after the same period of the prior year, also contributed to revenue growth. - FY2017AdvancedAnnual report
「㈲イノセ商事 became a consolidated subsidiary from the current fiscal year following the acquisition of its shares on 1 February 2017, and ㈱エム・シー became a consolidated subsidiary following the acquisition of its shares on 1 April 2017.」
Following the acquisition of 有限会社イノセ商事, the Company additionally acquired shares in 株式会社エム・シー and made it a consolidated subsidiary, advancing the expansion of its dispensing pharmacy business. - FY2017-Q3AdvancedAnnual report
「This was because the Company acquired all of the issued shares of 有限会社イノセ商事 for cash consideration.」
On 31 January 2017, the Company acquired 100% of the voting rights of 有限会社イノセ商事. The ¥133 million acquisition was intended to expand the dispensing pharmacy business, improve efficiency through integrated back-office operations and strengthen competitiveness. - FY2017-Q2RestatedAnnual report
「Against this backdrop, our group continues to expand its business base through new store openings and M&A, while seeking to respond to the business environment by further promoting community healthcare, including home healthcare and institutional dispensing services, expanding the use of generic drugs, and encouraging the adoption of electronic medication notebooks.」
The Group continues to pursue expansion of its business platform through new store openings and M&A, but does not disclose specific progress such as the completion of a new acquisition. - FY2017-Q1RestatedAnnual report
「Against this backdrop, the Group continues to expand its business platform through new store openings and M&A.」
The Group continues to promote expansion of its business platform through new store openings and M&A. - FY2016First statedAnnual report
「Our group continues to expand its business platform through new store openings, including stores serving multiple local healthcare providers, and M&A.」
The group continues to pursue expansion of its business platform through new store openings and M&A.